Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2025-12-16 @ 8:34 PM
Study NCT ID:
NCT06517433
Status:
None
Last Update Posted:
2024-07-24 00:00:00
First Post:
2024-07-18 00:00:00
Brief Title:
First-in-Human Dose Escalation Study of XMT-1536 in Cancers Likely to Express NaPi2b
Sponsor:
None
Organization:
Mersana Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-09
Completion Date Type:
ACTUAL
First Submit Date:
2024-07-18 00:00:00
First Submit QC Date:
None
Study First Post Date:
2024-07-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-18 00:00:00
Last Update Post Date:
2024-07-24 00:00:00
Last Update Post Date Type:
ACTUAL